Patents by Inventor Marcelo Gottschalk

Marcelo Gottschalk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180271969
    Abstract: The present invention relates to an immunogenic composition comprising polysaccharide-protein conjugates wherein each conjugate contains a capsular polysaccharide prepared from Streptococcus suis serotypes 1, 2, 7 and/or 9 or any other serotype conjugated to a carrier protein. The immunogenic composition is useful for the protection of disease in an animal subject.
    Type: Application
    Filed: October 6, 2016
    Publication date: September 27, 2018
    Applicants: Boehringer Ingelheim Vetmedica, Inc., Université de Montréal, Université du Québec à Montréal
    Inventors: Marcelo GOTTSCHALK, Guillaume GOYETTE-DESJARDINS, Jennifer Anne Kempker, Axel NEUBAUER, René ROY, Mariela SEGURA, Tze Chieh SHIAO
  • Patent number: 7927608
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: September 1, 2006
    Date of Patent: April 19, 2011
    Assignee: Valorisation—Recherche Limited Partnership
    Inventors: Josée Harel, Marcelo Gottschalk, Yuanyi Li
  • Publication number: 20090220513
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Application
    Filed: September 1, 2006
    Publication date: September 3, 2009
    Applicant: Universite de Montreal
    Inventors: Josee Harel, Marcelo Gottschalk, Yuanyi Li
  • Patent number: 6350584
    Abstract: The present invention relates to an ELISA diagnostic kit for the assay of A. pleuropneumoniae serotype 2 antibodies in the serum of pigs comprising in separate packaging, at least one of the following: a) a plate or solid support having bound thereto a purified lipopolysaccharide A. pleuropneumoniae serotype 2 antigen for a specific binding to anti-A. pleuropneumoniae serotype 2 antibodies present in the serum of pigs; b) serum from pigs experimentally inoculated with a strain of A. pleuropneumoniae serotype 2 to serve as a positive control; c) pig serum from A. pleuropneumoniae free herd to serve as a negative control; and d) a detectably labeled conjugate which bind to pigs antibodies bound to the plate of a).
    Type: Grant
    Filed: August 9, 1999
    Date of Patent: February 26, 2002
    Assignee: Universite de Montreal
    Inventors: Marcelo Gottschalk, Daniel Dubreuil, Réal Lallier
  • Patent number: 6270985
    Abstract: The present invention relates to an ELISA diagnostic kit for the assay of A. pleuropneumoniae serotypes 5a and 5b antibodies in the serum of pigs comprising in separate packaging, at least one of the following: a) a plate or solid support having bound thereto a purified lipopolysaccharide A. pleuropneumoniae serotype 5 antigen for a specific binding to anti-A. pleuropneumoniae serotypes 5a or 5b antibodies present in the serum of pigs; b) serum from pigs experimentally inoculated with a strain of A. pleuropneumoniae serotypes 5 to serve as a positive control; c) pig serum from A. pleuropneumoniae free herd to serve as a negative control; and d) a detectably labeled conjugate which bind to pigs antibodies bound to the plate of a).
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: August 7, 2001
    Assignee: Universite de Montreal
    Inventors: Marcelo Gottschalk, Daniel Dubreuil, Réal Lallier
  • Patent number: 6218195
    Abstract: The present invention relates to an ELISA diagnostic kit for the assay of A. pleuropneumoniae serotypes 1, 9 or 11 antibodies in the serum of pigs comprising in separate packaging, at least one of the following: a) a plate or solid support having bound thereto a purified lipopolysaccharide A. pleuropneumoniae serotype 1 antigen for a specific binding to anti-A. pleuropneumoniae serotypes 1, 9 or 11 antibodies present in the serum of pigs; b) serum from pigs experimentally inoculated with a strain of A. pleuropneumoniae serotypes 1 to serve as a positive control; c) pig serum from A. pleuropneumoniae free herd to serve as a negative control; and d) a detectably labeled conjugate which bind to pigs antibodies bound to the plate of a).
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: April 17, 2001
    Assignee: Universite de Montreal
    Inventors: Marcelo Gottschalk, Daniel Dubreuil, Réal Lallier
  • Patent number: RE45467
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: April 14, 2015
    Assignee: Valorisation-Recherche, Limited Partnership
    Inventors: Josee Harel, Marcelo Gottschalk, Yuanyi Li
  • Patent number: RE46285
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: January 24, 2017
    Assignee: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
    Inventors: Josée Harel, Marcelo Gottschalk, Yuanyi Li
  • Patent number: RE47164
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: December 18, 2018
    Assignee: Valorisation-Recherche Limited Partnership
    Inventors: Josee Harel, Marcelo Gottschalk, Yuanyi Li